ONCOOnconetixONCO info
$0.36info-5.76%24h
Global rank
Market cap$0
Change 7d-20.53%
YTD Performance78.22%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Business data

    Onconetix (ONCO) Stock Overview

    Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

    ONCO Stock Information

    Symbol
    ONCO
    Address
    201 East Fifth StreetCincinnati, OH 45202United States
    Founded
    -
    Trading hours
    -
    Website
    https://onconetix.gcs-web.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    513 620 4101

    Onconetix (ONCO) Price Chart

    -
    Value:-

    Onconetix Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.36000001
    N/A
    Employees
    12.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org